In vivo cancer-associated fibroblast specific gene silencing for anti-stromal therapy in primary liver cancer using novel siRNA loaded polypeptoide nanoparticles
Paul M. Schneider(Heidelberg University), Leonard Kaps(Saarland University), Alexandros Marios Sofias, Matthias Bros(Johannes Gutenberg University Mainz), Barbara Schoers, Peter R. Galle(Johannes Gutenberg University Mainz), Heyang Zhang(Academy of Military Medical Sciences), Matthias Barz(Johannes Gutenberg University Mainz), Mustafa Diken, Twan Lammers(RWTH Aachen University), Oezlem Akilli-Oeztuerk, Leon Capelôa, Markus Möhler(Heidelberg University), Karina Benderski(Universitätsklinikum Aachen)
Cited by 0
Related Papers
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k